Peters-Engl C - Search Results

1

Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases.

Peters-Engl C, Frank W, Kerschbaum F, Denison U, Medl M, Sevelda P. Peters-Engl C, et al. Breast Cancer Res Treat. 2001 Nov;70(2):131-5. doi: 10.1023/a:1012907308443. Breast Cancer Res Treat. 2001. PMID: 11768603

2

Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.

Denison U, Baumann J, Peters-Engl C, Samonigg H, Krippl P, Lang A, Obermair A, Wagner H, Sevelda P. Denison U, et al. Among authors: peters engl c. Breast Cancer Res Treat. 2003 Jun;79(3):347-53. doi: 10.1023/a:1024016508925. Breast Cancer Res Treat. 2003. PMID: 12846419

3

Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer.

Peters-Engl C, Cassik P, Schmidt I, Denison U, Medl M, Pokieser W, Sevelda P. Peters-Engl C, et al. Acta Oncol. 2005;44(2):129-33. doi: 10.1080/02841860510007530. Acta Oncol. 2005. PMID: 15788291

4

Color-coded and spectral Doppler flow in breast carcinomas--relationship with the tumor microvasculature.

Peters-Engl C, Medl M, Mirau M, Wanner C, Bilgi S, Sevelda P, Obermair A. Peters-Engl C, et al. Breast Cancer Res Treat. 1998 Jan;47(1):83-9. doi: 10.1023/a:1005992916193. Breast Cancer Res Treat. 1998. PMID: 9493979

5

Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival.

Peters-Engl C, Frank W, Leodolter S, Medl M. Peters-Engl C, et al. Breast Cancer Res Treat. 1999 Mar;54(1):65-71. doi: 10.1023/a:1006148812831. Breast Cancer Res Treat. 1999. PMID: 10369082

6

Association between endometrial cancer and tamoxifen treatment of breast cancer.

Peters-Engl C, Frank W, Danmayr E, Friedl HP, Leodolter S, Medl M. Peters-Engl C, et al. Breast Cancer Res Treat. 1999 Apr;54(3):255-60. doi: 10.1023/a:1006126411210. Breast Cancer Res Treat. 1999. PMID: 10445424

7

CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer.

Peters-Engl C, Obermair A, Heinzl H, Buxbaum P, Sevelda P, Medl M. Peters-Engl C, et al. Br J Cancer. 1999 Oct;81(4):662-6. doi: 10.1038/sj.bjc.6690744. Br J Cancer. 1999. PMID: 10574252 Free PMC article.

8

Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? A clinical study.

Peters-Engl C, Medl M, Denison U, Sevelda P, Leodolter S, Petru E. Peters-Engl C, et al. Anticancer Res. 2001 Sep-Oct;21(5):3701-6. Anticancer Res. 2001. PMID: 11848547 Clinical Trial.

9

The use of colour-coded and spectral Doppler ultrasound in the differentiation of benign and malignant breast lesions.

Peters-Engl C, Medl M, Leodolter S. Peters-Engl C, et al. Br J Cancer. 1995 Jan;71(1):137-9. doi: 10.1038/bjc.1995.28. Br J Cancer. 1995. PMID: 7819029 Free PMC article.

10

The use of color-coded Doppler sonography in the diagnosis of breast cancer.

Medl M, Peters-Engl C, Leodolter S. Medl M, et al. Anticancer Res. 1994 Sep-Oct;14(5B):2249-51. Anticancer Res. 1994. PMID: 7840531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters